🚀 VC round data is live in beta, check it out!
Cellebrite Valuation Multiples
Discover revenue and EBITDA valuation multiples for Cellebrite and similar public comparables like QiAnXin, Qualys, BlackBerry, Varonis Systems and more.
Cellebrite Overview
About Cellebrite
Cellebrite DI Ltd is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze, and manage digital data. Some of its products include Cellebrite UFED, Cellebrite Physical Analyzer, Cellebrite UFED Cloud, Cellebrite Frontliner, Cellebrite Responder, Cellebrite Premium, and Cellebrite Seeker.
Founded
1999
HQ
Employees
1.2K
Website
Financials (LTM)
EV
$3B
Cellebrite Financials
Cellebrite reported last 12-month revenue of $503M and EBITDA of $135M.
In the same LTM period, Cellebrite generated $425M in gross profit, $135M in EBITDA, and $83M in net income.
Revenue (LTM)
Cellebrite P&L
In the most recent fiscal year, Cellebrite reported revenue of $476M and EBITDA of $128M.
Cellebrite expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $503M | XXX | $476M | XXX | XXX | XXX |
| Gross Profit | $425M | XXX | $401M | XXX | XXX | XXX |
| Gross Margin | 84% | XXX | 84% | XXX | XXX | XXX |
| EBITDA | $135M | XXX | $128M | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 27% | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 24% | XXX | XXX | XXX |
| Net Profit | $83M | XXX | $78M | XXX | XXX | XXX |
| Net Margin | 17% | XXX | 16% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Cellebrite Stock Performance
Cellebrite has current market cap of $3B, and enterprise value of $3B.
Market Cap Evolution
Cellebrite's stock price is $13.18.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $3B | 0.0% | XXX | XXX | XXX | $0.31 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCellebrite Valuation Multiples
Cellebrite trades at 5.7x EV/Revenue multiple, and 21.3x EV/EBITDA.
EV / Revenue (LTM)
Cellebrite Financial Valuation Multiples
As of April 19, 2026, Cellebrite has market cap of $3B and EV of $3B.
Equity research analysts estimate Cellebrite's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Cellebrite has a P/E ratio of 39.5x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV/Revenue | 5.7x | XXX | 6.0x | XXX | XXX | XXX |
| EV/EBITDA | 21.3x | XXX | 22.5x | XXX | XXX | XXX |
| EV/EBIT | 24.2x | XXX | 25.6x | XXX | XXX | XXX |
| EV/Gross Profit | 6.8x | XXX | 7.2x | XXX | XXX | XXX |
| P/E | 39.5x | XXX | 42.0x | XXX | XXX | XXX |
| EV/FCF | 17.4x | XXX | 17.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cellebrite Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Cellebrite Margins & Growth Rates
Cellebrite's revenue in the last 12 month grew by 19%.
Cellebrite's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Cellebrite's rule of 40 is 46% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Cellebrite's rule of X is 75% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Cellebrite Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 19% | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | 27% | XXX | 27% | XXX | XXX | XXX |
| EBITDA Growth | 20% | XXX | 19% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 46% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 75% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 31% | XXX | 33% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 13% | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 23% | XXX | 24% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 70% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Cellebrite Public Comps
See public comps and valuation multiples for other Cybersecurity and Public Sector & Non-Profit Software comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Cellebrite | XXX | XXX | XXX | XXX | XXX | XXX |
| QiAnXin | XXX | XXX | XXX | XXX | XXX | XXX |
| Qualys | XXX | XXX | XXX | XXX | XXX | XXX |
| BlackBerry | XXX | XXX | XXX | XXX | XXX | XXX |
| Varonis Systems | XXX | XXX | XXX | XXX | XXX | XXX |
| Venustech Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Cellebrite M&A Activity
Cellebrite acquired XXX companies to date.
Last acquisition by Cellebrite was on XXXXXXXX, XXXXX. Cellebrite acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Cellebrite
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialCellebrite Investment Activity
Cellebrite invested in XXX companies to date.
Cellebrite made its latest investment on XXXXXXXX, XXXXX. Cellebrite invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Cellebrite
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cellebrite
| When was Cellebrite founded? | Cellebrite was founded in 1999. |
| Where is Cellebrite headquartered? | Cellebrite is headquartered in Israel. |
| How many employees does Cellebrite have? | As of today, Cellebrite has over 1K employees. |
| Who is the CEO of Cellebrite? | Cellebrite's CEO is Thomas E. Hogan. |
| Is Cellebrite publicly listed? | Yes, Cellebrite is a public company listed on Nasdaq. |
| What is the stock symbol of Cellebrite? | Cellebrite trades under CLBT ticker. |
| When did Cellebrite go public? | Cellebrite went public in 2021. |
| Who are competitors of Cellebrite? | Cellebrite main competitors are QiAnXin, Qualys, BlackBerry, Varonis Systems. |
| What is the current market cap of Cellebrite? | Cellebrite's current market cap is $3B. |
| What is the current revenue of Cellebrite? | Cellebrite's last 12 months revenue is $503M. |
| What is the current revenue growth of Cellebrite? | Cellebrite revenue growth (NTM/LTM) is 19%. |
| What is the current EV/Revenue multiple of Cellebrite? | Current revenue multiple of Cellebrite is 5.7x. |
| Is Cellebrite profitable? | Yes, Cellebrite is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Cellebrite? | Cellebrite's last 12 months EBITDA is $135M. |
| What is Cellebrite's EBITDA margin? | Cellebrite's last 12 months EBITDA margin is 27%. |
| What is the current EV/EBITDA multiple of Cellebrite? | Current EBITDA multiple of Cellebrite is 21.3x. |
| What is the current FCF of Cellebrite? | Cellebrite's last 12 months FCF is $165M. |
| What is Cellebrite's FCF margin? | Cellebrite's last 12 months FCF margin is 33%. |
| What is the current EV/FCF multiple of Cellebrite? | Current FCF multiple of Cellebrite is 17.4x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.